TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis

OncoImmunology

Volumn 1, Issue 6, 2012, Pages 917-923

  Seya, Tsukasa ^a   Shime, Hiroaki ^a   Takaki, Hiromi ^a   Azuma, Masahiro ^a   Oshiumi, Hiroyuki ^a   Matsumoto, Misako ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Interferon inducing pathway; Necroptosis; RIP signaling; TICAM 1; TLR3; TRIF

Indexed keywords

ADAPTOR PROTEIN; BIOLOGICAL MARKER; CASPASE 8; DAMP PROTEIN; DOUBLE STRANDED RNA; HYBRID PROTEIN; INTERFERON; NECROSOME; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE; RIP1 PROTEIN; RIP3 PROTEIN; TICAM 1 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RNA;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; HUMAN; INFLAMMATION; MACROPHAGE; NECROPTOSIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR MICROENVIRONMENT;

EID: 84876213017     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21244     Document Type: Article

References (50)

1. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al.; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16:3-11; PMID:18846107; http://dx.doi.org/10.1038/cdd.2008.150.
2. Tait SW, Green DR. Caspase-independent cell death: leaving the set without the final cut. Oncogene 2008; 27:6452-61; PMID:18955972; http://dx.doi.org/10.1038/onc.2008.311.
3. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003; 278:49751-62; PMID:14519765; http://dx.doi.org/10.1074/jbc.M305820200.
4. Ermolaeva MA, Michallet MC, Papadopoulou N, Utermöhlen O, Kranidioti K, Kollias G, et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008; 9:1037-46; PMID:18641654; http://dx.doi.org/10.1038/ni.1638.
5. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43:449-63; PMID:21737330; http://dx.doi.org/10.1016/j.molcel.2011.06.011.
6. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295-8; PMID:9363937; http://dx.doi.org/10.1016/S0092-8674(00)80412-2.
7. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291-5; PMID:20075244; http://dx.doi. org/10.1126/science.1183021.
8. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 2008; 1143:1-20; PMID:19076341; http://dx.doi.org/10.1196/annals.1443.020.
9. Morris S, Swanson MS, Lieberman A, Reed M, Yue Z, Lindell DM, et al. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. J Immunol 2011; 187:3953-61; PMID:21911604; http://dx.doi.org/10.4049/jimmunol.1100524.
10. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13:851-6; PMID:17572686; http://dx.doi.org/10.1038/nm1603.
11. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8:279-89; PMID:18340345; http://dx.doi.org/10.1038/nri2215.
12. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205:2609-21; PMID:18838547; http://dx.doi.org/10.1084/jem.20081370.
13. He S, Liang Y, Shao F, Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A 2011; 108:20054- 9; PMID:22123964; http://dx.doi.org/10.1073/ pnas.1116302108.
14. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279:12542-50; PMID:14729660; http://dx.doi.org/10.1074/jbc.M310175200.
15. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325:332-6; PMID:19498109; http://dx.doi.org/10.1126/science.1172308.
16. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010; 3:re4; PMID:20354226; http://dx.doi.org/10.1126/ scisignal.3115re4.
17. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137:1100-11; PMID:19524512; http://dx.doi.org/10.1016/j.cell.2009.05.021.
18. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137:1112-23; PMID:19524513; http://dx.doi.org/10.1016/j.cell.2009.05.037.
19. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011; 471:368-72; PMID:21368762; http://dx.doi.org/10.1038/nature09857.
20. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008; 4:e1000018; PMID:18516228; http://dx.doi.org/10.1371/journal.ppat.1000018.
21. Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/ DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012; 11:290-7; PMID:22423968; http://dx.doi.org/10.1016/j.chom.2012.01.016.
22. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501-5; PMID:17618271; http://dx.doi.org/10.1038/nature06013.
23. Shisler JL, Moss B. Immunology 102 at poxvirus U: avoiding apoptosis. Semin Immunol 2001; 13:67-72; PMID:11289801; http://dx.doi.org/10.1006/ smim.2000.0297.
24. Saeed M, Shiina M, Date T, Akazawa D, Watanabe N, Murayama A, et al. In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis. Hepatology 2011; 54:425-33; PMID:21538444; http://dx.doi.org/10.1002/hep.24399.
25. Salaun B, Romero P, Lebecque S. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur J Immunol 2007; 37:3311-8; PMID:18034428; http://dx.doi.org/10.1002/eji.200737744.
26. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010; pii: 672395.
27. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008; 451:725-9; PMID:18256672; http://dx.doi.org/10.1038/nature06537.
28. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009; 462:99-103; PMID:19890330; http://dx.doi.org/10.1038/ nature08512.
29. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 2008; 10:1349-55; PMID:18820689; http://dx.doi.org/10.1038/ncb1794.
30. Ahrens S, Zelenay S, Sancho D, Hanc P, Kjær S, Feest C, et al. F-actin is an evolutionarily conserved damageassociated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012; 36:635-45; PMID:22483800; http://dx.doi.org/10.1016/j.immuni. 2012.03.008.
31. Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012; 36:646-57; PMID:22483802; http://dx.doi.org/10.1016/j.immuni.2012.03.009.
32. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009; 85:905-10; PMID:19276179; http://dx.doi.org/10.1189/jlb.0109005.
33. Pedra JH, Cassel SL, Sutterwala FS. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009; 21:10-6; PMID:19223160; http://dx.doi.org/10.1016/j.coi.2009.01.006.
34. Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009; 21:194-8; PMID:19501527; http://dx.doi.org/10.1016/j.smim.2009.05.002.
35. Yu HB, Finlay BB. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 2008; 4:198-208; PMID:18779046; http://dx.doi.org/10.1016/j.chom.2008.08.007.
36. Seya T, Shime H, Ebihara T, Oshiumi H, Matsumoto M. Pattern recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci 2010; 101:313-20; PMID:20059475; http://dx.doi.org/10.1111/j.1349-7006.2009.01442.x.
37. Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011; 208:2357-66; PMID:22065672; http://dx.doi.org/10.1084/jem.20111171.
38. Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005; 433:887-92; PMID:15711573; http://dx.doi.org/10.1038/nature03326.
39. Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009; 206:1589-602; PMID:19564349; http://dx.doi.org/10.1084/jem.20090247.
40. Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 2006; 16:154-61; PMID:16474428; http://dx.doi.org/10.1038/sj.cr.7310021.
41. Zhang Y, Kim HJ, Yamamoto S, Kang X, Ma X. Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells. J Interferon Cytokine Res 2010; 30:113-22; PMID:20187777; http://dx.doi.org/10.1089/jir.2010.0004.
42. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623; PMID:10358769; http://dx.doi.org/10.1146/annurev.immunol.17.1.593.
43. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010; 11:785-97; PMID:20720586; http://dx.doi.org/10.1038/ni.1923.
44. Wakasa K, Shime H, Kurita-Taniguchi M, Matsumoto M, Imamura M, Seya T. Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells. Microbiol Immunol 2011; 55:373-7; PMID:21517948; http://dx.doi.org/10.1111/j.1348-0421.2011.00319.x.
45. Mantovani A. La mala educación of tumor-associated macrophages: Diverse pathways and new players. Cancer Cell 2010; 17:111-2; PMID:20159603; http://dx.doi.org/10.1016/j.ccr.2010.01.019.
46. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356:2131-42; PMID:17522398; http://dx.doi.org/10.1056/NEJMoa067208.
47. Shime H, Matsumoto M, Oshiumi H, Tanaka S, Nakane A, Iwakura Y, et al. Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci U S A 2012; 109:2066-71; PMID:22308357; http://dx.doi.org/10.1073/pnas.1113099109.
48. Ishii KJ, Akira S. Toll or toll-free adjuvant path toward the optimal vaccine development. J Clin Immunol 2007; 27:363-71; PMID:17370119; http://dx.doi.org/10.1007/s10875-007-9087-x.
49. Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother 2009; 58:1175-84; PMID:19184005; http://dx.doi.org/10.1007/s00262-008-0652-9.
50. Galluzzi L, Vacchelli E, Eggemont A, Fridman WH, Galon J, Sautes-Fridman C, et al. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. OncoImmunol. 2012; 1(5):699-717; PMID: 3429574; http://dx.doi.org/10.4161/onci.20696.